Performance and safety of therapeutic erythrocytapheresis in polycythemia and hemochromatosis treatment: single centre experience
Abstarct: Introduction: Therapeutic erythrocytapheresis has some advantages over therapeutic phlebotomy, the standard treatment for cytoreduction in polycythemia and hemochromatosis. Erythrocytapheresis can be performed on different cell separators, each with its own characteristics. We present our...
Saved in:
| Main Authors: | Iva Lucija Burnać, Ines Bojanić, Sanja Mazić, Marija Lukić, Branka Golubić Ćepulić |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S253113792400316X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of therapeutic erythrocytapheresis on outcomes and renal benefit in patients with high-altitude polycythemia: a real-world study
by: Yan Ouyang, et al.
Published: (2024-11-01) -
Determining level of endogenous serum erythropoietin for differential diagnosis of polycythemia vera and symptomatic polycythemia
by: Kostyukevych O.M.
Published: (2013-06-01) -
The management of vascular access in therapeutic apheresis
by: JIANG Ying, et al.
Published: (2025-01-01) -
Renal Cell Carcinoma with Polycythemia
by: Asaad I Othman ., et al.
Published: (2021-06-01) -
Polycythemia vera: Correlation of JAK2V617F mutation with clinicohematologic characteristics. A single centre experience.
by: Deepti Mutreja, et al.
Published: (2014-08-01)